New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced the execution of an agreement and plan of merger (the “Merger Agreement”) with Shenzhen Qianzhi BioTechnology Co., Ltd (“Qianzhi BioTech”), a biotech company engaged in development, manufac...

NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (the “Company”) announced today that it closed the sale of an additional 900,000 units at $10.00 per unit for aggregate gross proceeds of $9,000,000 pursuant to the underwriters’ over-allotment option granted in connection with the Company’s initial public offering. Tot...

NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (the “Company”) announced today that it closed its initial public offering of 6,000,000 units at $10.00 per unit. The offering resulted in gross proceeds to the Company of $60,000,000.